Michael D. Weil

Dr. Weil is a developer of low-cost, healthcare devices for under-served regions, and an innovator in low-energy, x-ray therapy of advanced cancers. He is a founder of Sirius Medicine, which licensed kilovoltage (kV) x-rayoptics to Siemens, and developed clinically validated, kVx-ray therapeutics, including contrast-enhanced radiotherapy (CERT), and radiation-based immunotherapy. He conducted the first clinical trials of kV radiosurgery, as well as kV-based immunotherapy, and has performed over 200 such procedures on patients. Dr. Weil has served on the faculty of the Departments of Radiation Oncology at the University of California, San Francisco, and the University of Colorado. He has been the author and principal investigator of a dozen submitted clinical oncology trials. Dr. Weil holds five U.S. patents and several others pending.